Verma S - Search Results

1

Systemic therapy for advanced uterine sarcoma: a systematic review of the literature.

Kanjeekal S, Chambers A, Fung MF, Verma S. Kanjeekal S, et al. Among authors: verma s. Gynecol Oncol. 2005 May;97(2):624-37. doi: 10.1016/j.ygyno.2005.01.041. Gynecol Oncol. 2005. PMID: 15863170 Review.

2

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.

Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M, Johnston M. Covens A, et al. Among authors: verma s. Gynecol Oncol. 2002 Apr;85(1):71-80. doi: 10.1006/gyno.2001.6552. Gynecol Oncol. 2002. PMID: 11925123 Review.

3

Dose-intensive chemotherapy in advanced adult soft tissue sarcoma.

Verma S, Bramwell V. Verma S, et al. Expert Rev Anticancer Ther. 2002 Apr;2(2):201-15. doi: 10.1586/14737140.2.2.201. Expert Rev Anticancer Ther. 2002. PMID: 12113242 Review.

4

Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen.

Dranitsaris G, Verma S, Trudeau M. Dranitsaris G, et al. Among authors: verma s. Am J Clin Oncol. 2003 Jun;26(3):289-96. doi: 10.1097/01.COC.0000021042.55557.2B. Am J Clin Oncol. 2003. PMID: 12796603

5

Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.

Fung MF, Reid A, Faught W, Le T, Chenier C, Verma S, Brydon E, Fung KF. Fung MF, et al. Among authors: verma s. Gynecol Oncol. 2003 Oct;91(1):154-9. doi: 10.1016/s0090-8258(03)00441-4. Gynecol Oncol. 2003. PMID: 14529676

6

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.

Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S. Trudeau M, et al. Among authors: verma s. Lancet Oncol. 2005 Nov;6(11):886-98. doi: 10.1016/S1470-2045(05)70424-1. Lancet Oncol. 2005. PMID: 16257797 Review.

7

Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.

Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N. Verma S, et al. Cancer. 2006 Apr 1;106(7):1431-42. doi: 10.1002/cncr.21760. Cancer. 2006. PMID: 16511841 Free article. Review.

8

Temozolomide for the treatment of metastatic melanoma: a systematic review.

Quirt I, Verma S, Petrella T, Bak K, Charette M. Quirt I, et al. Among authors: verma s. Oncologist. 2007 Sep;12(9):1114-23. doi: 10.1634/theoncologist.12-9-1114. Oncologist. 2007. PMID: 17914081 Free article. Review.

9

Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review.

Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Verma S, et al. Cancer. 2008 Mar 15;112(6):1197-205. doi: 10.1002/cncr.23302. Cancer. 2008. PMID: 18224666 Free article. Review.

10

Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.

Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Verma S, et al. Cancer Treat Rev. 2008 Jun;34(4):339-47. doi: 10.1016/j.ctrv.2008.01.005. Epub 2008 Mar 3. Cancer Treat Rev. 2008. PMID: 18313854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,400 results

Search Page